Lysosomal-Associated Membrane Protein 2
"Lysosomal-Associated Membrane Protein 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.
| Descriptor ID |
D052119
|
| MeSH Number(s) |
D12.776.395.550.550.750 D12.776.543.550.527.750
|
| Concept/Terms |
Lysosomal-Associated Membrane Protein 2- Lysosomal-Associated Membrane Protein 2
- Lysosomal Associated Membrane Protein 2
- LAMP2 Protein
- Antigens, CD107b
- LGP-B Protein
- LGP B Protein
- CD107b Antigens
- CD107b Antigen
- LGP110 Protein
|
Below are MeSH descriptors whose meaning is more general than "Lysosomal-Associated Membrane Protein 2".
Below are MeSH descriptors whose meaning is more specific than "Lysosomal-Associated Membrane Protein 2".
This graph shows the total number of publications written about "Lysosomal-Associated Membrane Protein 2" by people in this website by year, and whether "Lysosomal-Associated Membrane Protein 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lysosomal-Associated Membrane Protein 2" by people in Profiles.
-
Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation. Toxicol In Vitro. 2015 Feb; 29(1):195-203.
-
Degradation of AF1Q by chaperone-mediated autophagy. Exp Cell Res. 2014 Sep 10; 327(1):48-56.
-
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. Hum Mol Genet. 2010 Mar 15; 19(6):1088-97.